Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 57,773 | 69,221 | 60,421 | 93,914 | 88,517 |
| Cost of Goods | 4,677 | 6,273 | 4,638 | 6,467 | 7,707 |
| Gross Profit | 53,096 | 62,948 | 55,783 | 87,447 | 80,810 |
| Operating Expenses | 51,508 | 56,777 | 54,171 | 56,915 | 45,138 |
| Operating Income | 2,265 | 6,444 | 2,250 | 30,999 | 36,379 |
| Other Income | 281 | 251 | 274 | 187 | 91 |
| Pre-tax Income | 2,546 | 6,695 | 2,524 | 31,186 | 36,470 |
| Income Tax | -379 | 668 | 234 | 13,043 | 11,840 |
| Net Income Continuous | 2,925 | 6,027 | 2,290 | 18,143 | 24,630 |
| Net Income | $2,925 | $6,027 | $2,290 | $18,143 | $24,630 |
| EPS Basic Total Ops | 0.04 | 0.08 | 0.03 | 0.26 | 0.34 |
| EPS Basic Continuous Ops | 0.04 | 0.08 | 0.03 | 0.25 | 0.34 |
| EPS Diluted Total Ops | 0.04 | 0.08 | 0.03 | 0.25 | 0.32 |
| EPS Diluted Continuous Ops | 0.04 | 0.08 | 0.03 | 0.24 | 0.32 |
| EBITDA(a) | $4,245 | $8,494 | $4,346 | $33,038 | $38,126 |